These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8333231)

  • 41. [Heparin and plasminogen increase the thrombolytic potential in recanalization of peripheral arterial occlusions by local streptokinase].
    Poredos P; Videcnik V
    Vasa Suppl; 1992; 37():62-3. PubMed ID: 1481104
    [No Abstract]   [Full Text] [Related]  

  • 42. [Drug thrombolysis and mechanical recanalization in recent femoro-popliteal arterial occlusions].
    Beyssen B; Sapoval M; Hoffman O; Pagny JY; Raynaud A; Gaux JC
    J Radiol; 1995 Apr; 76(4):169-78. PubMed ID: 7745550
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequential treatment of arterial occlusions with porcine plasmin and low dose streptokinase.
    Marbet GA; Eichlisberger R; Duckert F; da Silva MA; Biland L; Widmer LK; Ritz R; Schmitt HE
    Thromb Haemost; 1982 Oct; 48(2):187-9. PubMed ID: 6217580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Results of modified ultra-high streptokinase lysis in patients with arterial occlusive disease. Preliminary report].
    Schmidtke I
    Vasa Suppl; 1993; 39():14-6. PubMed ID: 8322119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome.
    Eckert B; Kucinski T; Neumaier-Probst E; Fiehler J; Röther J; Zeumer H
    Cerebrovasc Dis; 2003; 15(4):258-63. PubMed ID: 12686789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Wegner CD; Cox BF
    Thromb Haemost; 1999 Feb; 81(2):301-5. PubMed ID: 10064010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Local fibrinolytic therapy of arterial occlusions of the lower extremity: initial success and clinical outcome].
    Müller-Lung U; Heindel W; Gawenda M; Lackner K
    Aktuelle Radiol; 1996 Nov; 6(6):325-9. PubMed ID: 9081405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Results of thrombolytic therapy in acute myocardial infarct].
    Gülker H; Ketteler T; Haverkamp W; Hindricks G
    Z Kardiol; 1988; 77 Suppl 4():23-36. PubMed ID: 2975098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Local fibrinolysis of peripheral arterial occlusions].
    Schwarzenberg H
    Rofo; 1998 Sep; 169(3):227-35. PubMed ID: 9779061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous transluminal angioplasty combined with intra-arterial thrombolysis to treat lower-extremity arterial occlusion in thromboangitis.
    Li FQ; Li L; He XW; Zhang MX; Wang W
    Int Angiol; 2016 Oct; 35(5):440-5. PubMed ID: 26406966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.
    Pilger E; Lammer J; Bertuch H; Steiner H
    Radiology; 1986 Dec; 161(3):597-9. PubMed ID: 3786705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ultrasound-enhanced Thrombolysis.
    Motarjeme A
    J Endovasc Ther; 2007 Apr; 14(2):251-6. PubMed ID: 17484537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catheter-directed thrombolysis of peripheral arterial occlusions and deep vein thrombosis.
    Kandarpa K
    Thromb Haemost; 1999 Aug; 82(2):987-96. PubMed ID: 10605814
    [No Abstract]   [Full Text] [Related]  

  • 55. [Peripheral arterial occlusive disease--acute intervention and after-care].
    Stenzinger W; van de Loo J
    Z Kardiol; 1993; 82 Suppl 5():71-7. PubMed ID: 8154165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions.
    Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP
    J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spotlight on reteplase in thrombotic occlusive disorders.
    Simpson D; Siddiqui MA; Scott LJ; Hilleman DE
    BioDrugs; 2007; 21(1):65-8. PubMed ID: 17263591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Percutaneous local thrombolytic therapy and thrombectomy in occlusion of extremity arteries].
    Schneider E; Hoffmann U
    Internist (Berl); 1996 Jun; 37(6):607-12. PubMed ID: 8767993
    [No Abstract]   [Full Text] [Related]  

  • 60. [Intraarterial urokinase infusion therapy for arterial occlusive disease of the pelvis and extremities with special reference to short-term high dose infusion].
    Kichikawa K; Nishimine K; Uchida H; Kubota Y; Yoshioka T; Honda N; Hirai T; Tamada T; Nishimura Y; Maeda M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Mar; 50(3):229-39. PubMed ID: 2345694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.